VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Nalbuphine plus Bupivacaine
Phase 3
Small molecule
A
Assiut University
1
Indications
2
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Postoperative Analgesia
1 trial
Effect of Caudal Nalbuphine on Postoperative Analgesia in Children
Completed
·
—
·
N/A
·
NCT02618876
·
60 enrolled
Agitation
1 trial
Effect of Intravenous Nalbuphine and Magnesium Sulfate on Emergence Agitation in Pediatric
Not yet recruiting
·
—
·
Phase 3
·
NCT06306040
·
105 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Nalbuphine plus Bupivacaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Nalbuphine plus Bupivacaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Nalbuphine plus Bupivacaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Assiut University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
A
Assiut University
Related News